Skip to main content
Hugel, Inc. logo

Hugel, Inc. — Investor Relations & Filings

Ticker · 145020 ISIN · KR7145020004 KO Manufacturing
Open in API
Filings indexed 499 across all filing types
Latest filing 2024-03-06 Legal Proceedings Report
Country KR South Korea
Listing KO 145020

About Hugel, Inc.

https://www.hugel-inc.com/

Hugel, Inc. is a global biopharmaceutical company specializing in the medical aesthetics and therapeutics market. The company develops, manufactures, and distributes a portfolio of high-quality products, including its flagship botulinum toxin type A formulations, known commercially as Botulax and Letybo. Its product line also features a range of hyaluronic acid (HA) fillers and PDO threads. Recognized as a leader in its field, Hugel is focused on providing innovative, efficient, and proven solutions to medical professionals worldwide. The company is committed to advancing aesthetic medicine through continuous research and development to create effective and reliable treatments.

Recent filings

Filing Released Lang Actions
기타경영사항(자율공시) (잠정 제조중지·판매중지명령, 회수폐기명령과 품목허가취소처분 및 전 제조번호 회수·폐기명령, 1개월의 판매업무정지처분에 대한 집행정지 인용 결정)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from Hugel regarding a court decision on an administrative litigation (stay of execution for manufacturing/sales suspension and product license cancellation). It details legal proceedings and their impact on the company's operations. Since it pertains to ongoing legal matters and regulatory actions, it falls under the 'Legal Proceedings Report' category.
2024-03-06 Korean
투자판단관련주요경영사항 (보툴렉스(Botulax, 수출명 Letybo) 50유닛,100유닛의 미국 품목허가 획득)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system regarding a material business event (FDA approval of a product). It is a formal disclosure of a significant corporate development, which falls under the category of general regulatory announcements as it does not fit into specific categories like financial reports, dividends, or share transactions.
2024-03-04 Korean
기타경영사항(자율공시) (제조판매중지명령등 취소의 소(품목허가취소처분등 취소의 소 병합) 1심 판결에 대한 원고 항소 및 효력정지신청의 건)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from Hugel regarding an ongoing legal proceeding (an appeal against a 1st-instance court ruling concerning manufacturing and sales suspension orders). It details the company's legal actions, including the filing of an appeal and a request for a stay of execution. Since this document pertains to significant legal matters and litigation updates rather than financial results, M&A, or governance, it falls under the 'Legal Proceedings Report' category.
2024-03-04 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings Classification · 95% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) filed by Hugel Co., Ltd. under the GS Group. It provides specific regulatory data regarding circular shareholding, voting rights of financial/insurance affiliates, and inter-affiliate transactions as required by Korean fair trade regulations. Since this is a mandatory regulatory disclosure filed with the authorities and does not fit into specific categories like financial reports or shareholder meeting materials, it is classified as a Regulatory Filing (RNS).
2024-02-29 Korean
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding the cancellation of a stock collateral agreement by the company's largest shareholder (Aphrodite Acquisition Holdings LLC). This type of disclosure, which details changes in collateral status for major shareholders, falls under the category of general regulatory announcements or corporate disclosures that do not fit into specific categories like director dealings or share issues. Therefore, it is classified as a Regulatory Filing (RNS).
2024-02-28 Korean
최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from the Korean DART system regarding a 'Pledge of Shares' (collateral provision) by the company's largest shareholder (Aphrodite Acquisition Holdings LLC). This type of disclosure, which details the pledging of shares for refinancing purposes, falls under the category of capital and financing updates as it relates to the company's capital structure and major shareholder obligations.
2024-02-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.